Meet us at 67th ASH Annual Meeting and Exposition
Meet our medical team to find out more about our clinical program and CAR-T therapies on December 6-9 in Orlando, Florida, USA
Meet us at 67th ASH Annual Meeting and Exposition
Meet our medical team to find out more about our clinical program and CAR-T therapies on December 6-9 in Orlando, Florida, USA
Join our oral presentation at ASH 2025
Join us during Oral Abstract Session 628: Aggressive Lymphomas for the presentation of the pivotal DALY 2-EU trial results
Abstract: Zamtocabtagene autoleucel, a tandem CD20-CD19 directed CAR-T cell therapy as second-line treatment for Relapsed/Refractory large B-cell lymphoma: primary analysis of the randomized, pivotal DALY 2-EU study
Where: Room OCCC - Tangerine Ballroom F3-4
When: Sunday, Dec 7, 2025, 5:00 p.m. - 5:15 p.m.
Session F: 628. Aggressive Lymphomas: Cellular Therapies: Novel Cellular Therapeutic Strategies for Aggressive Lymphomas
Miltenyi Biomedicine announces new zamtocabtagene autoleucel data to be presented at ASH 2025
New data from the DALY 2-EU study will be presented during the 67th Annual Meeting and Exposition in Orlando, USA. Download the full press release
We are looking forward to seeing you at #ASH25
We look forward to welcoming you to our booth (1271), where you will be able to speak to our medical team about our clinical program and open trials.
#ASH2025 will take place at the Orange County Convention Center in Orlando, Florida. You will find us at the Miltenyi Biomedicine booth 1271
Exhibition opening hours:
Saturday, 6 December, 11:00 a.m. - 5:00 p.m.
Sunday, 7 December, 10:00 a.m. - 5:00 p.m.
Monday, 8 December, 10:00 a.m. - 2:00 p.m.
